BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23578224)

  • 1. Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Oshima K; Kanda Y; Kako S; Ohno K; Kishino S; Kurokawa M
    Transpl Infect Dis; 2013 Jun; 15(3):323-7. PubMed ID: 23578224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
    Yoshikawa K; Nakazawa Y; Katsuyama Y; Hirabayashi K; Saito S; Shigemura T; Tanaka M; Yanagisawa R; Sakashita K; Koike K
    Infection; 2014 Aug; 42(4):639-47. PubMed ID: 24567233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of plasma exchange on pharmacokinetic disposition of micafungin.
    Konishi H; Fukushima K; Saotome T; Hamamoto T; Eguchi Y; Sudo M; Sumi M; Minouchi T; Iga I; Yamaji A
    Ther Apher Dial; 2010 Jun; 14(3):358-63. PubMed ID: 20609192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation.
    Hashino S; Morita L; Takahata M; Onozawa M; Nakagawa M; Kawamura T; Fujisawa F; Kahata K; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Asaka M
    Int J Hematol; 2008 Jan; 87(1):91-7. PubMed ID: 18224421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of liver and kidney function on migafungin disposition in patients with hematologic malignancies.
    Nakagawa Y; Ichii Y; Saeki Y; Kodama M; Kishino S; Suzuki K
    Eur J Drug Metab Pharmacokinet; 2008; 33(3):191-8. PubMed ID: 19007046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
    Mehta PA; Vinks AA; Filipovich A; Bleesing J; Jodele S; Jordan MB; Marsh R; Tarin R; Edwards S; Fearing D; Lawrence J; Davies SM
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1458-62. PubMed ID: 20546908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and safety profiles of repeated-dose prophylactic micafungin in children and adolescents undergoing hematopoietic stem cell transplantation.
    Albano E; Azie N; Roy M; Townsend R; Arrieta A
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e45-50. PubMed ID: 25072363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of total bilirubin on plasma micafungin levels in living-donor liver transplantation recipients with severe liver dysfunction.
    Muraki Y; Iwamoto T; Kagawa Y; Sakurai H; Usui M; Isaji S; Uemoto S; Okuda M
    Biol Pharm Bull; 2009 Apr; 32(4):750-4. PubMed ID: 19336919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in Germany.
    Heimann SM; Vehreschild MJ; Meintker L; Heinz W; Schroeder T; von Bergwelt-Baildon M; Cornely OA; Vehreschild JJ
    Transpl Infect Dis; 2014 Dec; 16(6):968-74. PubMed ID: 25371351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.
    Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Takada K; Yamaji A
    Fundam Clin Pharmacol; 2010 Aug; 24(4):457-62. PubMed ID: 19845766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
    Krishna G; Martinho M; Chandrasekar P; Ullmann AJ; Patino H
    Pharmacotherapy; 2007 Dec; 27(12):1627-36. PubMed ID: 18041883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of micafungin for febrile neutropenia in pediatric patients with hematological malignancies: a multicenter prospective study.
    Kobayashi R; Suzuki N; Yoshida M; Iizuka S; Suzuki D; Sano H; Kudoh T
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):e276-9. PubMed ID: 23743960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of micafungin in the tissue fluids of patients with invasive fungal infections.
    Yamada N; Kumada K; Kishino S; Mochizuki N; Ohno K; Ogura S
    J Infect Chemother; 2011 Oct; 17(5):731-4. PubMed ID: 21537970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micafungin: a brief review of pharmacology, safety, and antifungal efficacy in pediatric patients.
    Lehrnbecher T; Groll AH
    Pediatr Blood Cancer; 2010 Aug; 55(2):229-32. PubMed ID: 20583216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of micafungin into the burn eschar in patients with severe burns.
    Sasaki J; Yamanouchi S; Sato Y; Abe S; Shinozawa Y; Kishino S; Aikawa N; Hori S
    Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):93-7. PubMed ID: 23771854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic profile of micafungin when co-administered with amphotericin B in healthy male subjects.
    Undre NA; Stevenson P; Wilbraham D
    Int J Clin Pharmacol Ther; 2014 Mar; 52(3):237-44. PubMed ID: 24472403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of micafungin area under the curve data by using peak concentration: applicability and utility in antifungal therapy.
    Srinivas NR
    Future Microbiol; 2016; 11(4):485-90. PubMed ID: 27070500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients.
    Lempers VJ; Schouten JA; Hunfeld NG; Colbers A; van Leeuwen HJ; Burger DM; Verweij PE; Pickkers P; Brüggemann RJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4403-9. PubMed ID: 25963988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.